Nigel Brooksby
Director/Board Member chez DESTINY PHARMA PLC
Fortune : 112 373 $ au 31/03/2024
Profil
Nigel Stanley Brooksby is currently the Chairman of The European Medicines Agency, Chairman of Clinical Insights Ltd., Director of Industrial Development Advisory Board, and Non-Executive Director of Destiny Pharma Plc.
In the past, he served as Chairman-UK & Managing Director of Sanofi-Aventis U.S.
LLC, Chairman & Managing Director of Sanofi-Aventis Ltd., Chairman of Pertinax Pharma Ltd., Director of Novacta Biosystems Ltd., Non-Executive Director of Chronos Therapeutics Ltd., Non-Executive Director of Porton Biopharma Ltd., and President of The Association of the British Pharmaceutical Industry.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
DESTINY PHARMA PLC
0,37% | 18/11/2022 | 348 845 ( 0,37% ) | 112 373 $ | 31/03/2024 |
Postes actifs de Nigel Brooksby
| Sociétés | Poste | Début |
|---|---|---|
| DESTINY PHARMA PLC | Director/Board Member | 01/06/2022 |
| Industrial Development Advisory Board | Director/Board Member | 02/02/2011 |
Clinical Insights Ltd.
 Clinical Insights Ltd. Miscellaneous Commercial ServicesCommercial Services Clinical Insights Ltd. engages in the provision of advisory services to the pharmaceutical industry. The company is headquartered in Milan, Italy. | Chairman | - |
| The European Medicines Agency | Chairman | - |
Anciens postes connus de Nigel Brooksby
| Sociétés | Poste | Fin |
|---|---|---|
Porton Biopharma Ltd.
 Porton Biopharma Ltd. Pharmaceuticals: MajorHealth Technology Porton Biopharma Ltd. is a biopharmaceutical company based in Salisbury, UK. The British company is focused on the development and manufacture of biopharmaceutical products for the treatment of infectious diseases and cancer. Porton Biopharma is committed to delivering high-quality products that meet the needs of patients and healthcare providers. The CEO of the private company is Roger Hinton, who leads a team of experienced professionals dedicated to advancing the company's mission. | Director/Board Member | 01/05/2022 |
Chronos Therapeutics Ltd.
 Chronos Therapeutics Ltd. BiotechnologyHealth Technology Chronos Therapeutics Ltd. manufactures drugs. It pursuing innovative therapeutics for age-related diseases through the joint efforts of experts in medical research, drug discovery and business development. The company was founded in 2009 and is headquartered in Oxford, the United Kingdom. | Director/Board Member | 01/05/2022 |
Pertinax Pharma Ltd.
 Pertinax Pharma Ltd. Pharmaceuticals: MajorHealth Technology Pertinax Pharma Ltd. manufactures pharmaceutical products. developing medical, healthcare and veterinary applications of a novel, proprietary long acting formulation of the already widely used antimicrobial drug chlorhexidine. Pertinax Pharma was founded by Michele Barbour in 2015 and is headquartered in Bristol, the United Kingdom. | Chairman | 18/09/2019 |
Sanofi-Aventis U.S. LLC
 Sanofi-Aventis U.S. LLC Pharmaceuticals: MajorHealth Technology Sanofi-Aventis U.S. LLC engages in the provision of pharmaceutical products. It discovers, develops, produces and markets innovative therapies. The firm extensive research and development efforts are focused on health care challenges in cardiology, oncology and internal medicine, as well as metabolic diseases, central nervous system disorders, ophthalmology and vaccines. The company is headquartered in Bridgewater, NJ. | Corporate Officer/Principal | 31/08/2010 |
The Association of the British Pharmaceutical Industry
 The Association of the British Pharmaceutical Industry Miscellaneous Commercial ServicesCommercial Services The Association of the British Pharmaceutical Industry is a non-profit organization, which engages in the research and development of medicines. It focuses on biosciences. The company is headquartered in London, the United Kingdom. | President | - |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| DESTINY PHARMA PLC | Health Technology |
| Entreprise privées | 10 |
|---|---|
Sanofi-Aventis U.S. LLC
Sanofi-Aventis U.S. LLC Pharmaceuticals: MajorHealth Technology Sanofi-Aventis U.S. LLC engages in the provision of pharmaceutical products. It discovers, develops, produces and markets innovative therapies. The firm extensive research and development efforts are focused on health care challenges in cardiology, oncology and internal medicine, as well as metabolic diseases, central nervous system disorders, ophthalmology and vaccines. The company is headquartered in Bridgewater, NJ. | Health Technology |
Novacta Biosystems Ltd.
 Novacta Biosystems Ltd. BiotechnologyHealth Technology Novacta Biosystems Ltd. discovered and developed drugs for treatment of bacterial infections. Its products included lantibiotic/bacteriocin variants, as well as a development candidate for the treatment of C. difficile infection. The company was founded by John Michael Dawson on February 14, 2015 and was headquartered in London, the United Kingdom. | Health Technology |
The Association of the British Pharmaceutical Industry
The Association of the British Pharmaceutical Industry Miscellaneous Commercial ServicesCommercial Services The Association of the British Pharmaceutical Industry is a non-profit organization, which engages in the research and development of medicines. It focuses on biosciences. The company is headquartered in London, the United Kingdom. | Commercial Services |
| The European Medicines Agency | Government |
Sanofi-Aventis Ltd.
 Sanofi-Aventis Ltd. Pharmaceuticals: MajorHealth Technology Sanofi-Aventis Ltd. provides pharmaceutical services. It focuses on cardiovascular medicine, thrombosis, oncology, metabolic disorders and diseases of the central nervous system. The company was founded in December 2004 and is headquartered in Guildford, the United Kingdom. | Health Technology |
| Industrial Development Advisory Board | |
Chronos Therapeutics Ltd.
Chronos Therapeutics Ltd. BiotechnologyHealth Technology Chronos Therapeutics Ltd. manufactures drugs. It pursuing innovative therapeutics for age-related diseases through the joint efforts of experts in medical research, drug discovery and business development. The company was founded in 2009 and is headquartered in Oxford, the United Kingdom. | Health Technology |
Porton Biopharma Ltd.
Porton Biopharma Ltd. Pharmaceuticals: MajorHealth Technology Porton Biopharma Ltd. is a biopharmaceutical company based in Salisbury, UK. The British company is focused on the development and manufacture of biopharmaceutical products for the treatment of infectious diseases and cancer. Porton Biopharma is committed to delivering high-quality products that meet the needs of patients and healthcare providers. The CEO of the private company is Roger Hinton, who leads a team of experienced professionals dedicated to advancing the company's mission. | Health Technology |
Pertinax Pharma Ltd.
Pertinax Pharma Ltd. Pharmaceuticals: MajorHealth Technology Pertinax Pharma Ltd. manufactures pharmaceutical products. developing medical, healthcare and veterinary applications of a novel, proprietary long acting formulation of the already widely used antimicrobial drug chlorhexidine. Pertinax Pharma was founded by Michele Barbour in 2015 and is headquartered in Bristol, the United Kingdom. | Health Technology |
Clinical Insights Ltd.
Clinical Insights Ltd. Miscellaneous Commercial ServicesCommercial Services Clinical Insights Ltd. engages in the provision of advisory services to the pharmaceutical industry. The company is headquartered in Milan, Italy. | Commercial Services |
